|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
[Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein; [Cladribine co-treated with Cyclophosphamide] results in decreased expression of BCL2 protein; BCL2 affects the reaction [Cladribine results in increased cleavage of and results in increased activity of CASP9 protein]; BCL2 inhibits the reaction [Cladribine results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 inhibits the reaction [Cladribine results in increased cleavage of CASP8 protein] Cladribine results in decreased expression of BCL2 protein |
CTD |
PMID:15516989 PMID:15582267 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
Cladribine promotes the reaction [Bendamustine Hydrochloride results in decreased expression of BIRC3 protein] |
CTD |
PMID:12948851 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
BCL2 inhibits the reaction [Cladribine results in increased cleavage of and results in increased activity of CASP3 protein]; Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP3 protein]; Cladribine results in increased cleavage of and results in increased activity of CASP3 protein Cladribine results in increased activity of CASP3 protein |
CTD |
PMID:11672427 PMID:12948851 PMID:15516989 PMID:21679466 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
multiple interactions increases activity |
ISO |
Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP6 protein] Cladribine results in increased activity of CASP6 protein |
CTD |
PMID:11672427 PMID:12948851 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases activity |
ISO |
Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP7 protein] Cladribine results in increased activity of CASP7 protein |
CTD |
PMID:12948851 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases cleavage increases activity |
ISO |
[Valproic Acid co-treated with Cladribine] results in increased cleavage of CASP8 protein; BCL2 inhibits the reaction [Cladribine results in increased cleavage of CASP8 protein]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Cladribine results in increased cleavage of CASP8 protein]; Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP8 protein] Cladribine results in increased activity of CASP8 protein |
CTD |
PMID:11672427 PMID:12948851 PMID:15516989 PMID:19006566 PMID:21679466 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity |
ISO |
BCL2 affects the reaction [Cladribine results in increased cleavage of and results in increased activity of CASP9 protein]; Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP9 protein]; Cladribine results in increased cleavage of and results in increased activity of CASP9 protein Cladribine results in increased activity of CASP9 protein |
CTD |
PMID:11672427 PMID:12948851 PMID:15516989 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
ISO |
Cladribine results in increased expression of CDKN1A mRNA Cladribine promotes the reaction [resveratrol results in increased expression of CDKN1A mRNA]; resveratrol promotes the reaction [Cladribine results in increased expression of CDKN1A mRNA] |
CTD |
PMID:21801466 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Daxx |
death-domain associated protein |
multiple interactions |
ISO |
Cladribine promotes the reaction [Bendamustine Hydrochloride results in decreased expression of DAXX protein] |
CTD |
PMID:12948851 |
|
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
multiple interactions |
ISO |
Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased localization of DIABLO protein] |
CTD |
PMID:12948851 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions decreases expression |
ISO |
Cholecalciferol promotes the reaction [Cladribine results in decreased expression of DNMT1 mRNA]; Cladribine promotes the reaction [Cholecalciferol results in decreased expression of DNMT1 mRNA] |
CTD |
PMID:21801466 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Il4 |
interleukin 4 |
increases expression |
ISO |
Cladribine results in increased expression of IL4 mRNA |
CTD |
PMID:9751108 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
increases response to substance |
ISO |
KMT2A gene mutant form results in increased susceptibility to Cladribine |
CTD |
PMID:14712291 |
|
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
|
|
G |
Lmnb1 |
lamin B1 |
multiple interactions increases cleavage |
ISO |
[Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of LMNB1 protein; [Cladribine co-treated with Cyclophosphamide] results in decreased expression of LMNB1 protein Cladribine results in increased cleavage of LMNB1 protein |
CTD |
PMID:15582267 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Nt5c1a |
5'-nucleotidase, cytosolic IA |
decreases response to substance multiple interactions |
ISO |
NT5C1A protein results in decreased susceptibility to Cladribine NT5C1A protein results in decreased susceptibility to [Fluorouracil co-treated with Cladribine] |
CTD |
PMID:16362297 |
|
NCBI chr 5:135,473,107...135,494,400
Ensembl chr 5:135,473,231...135,499,338
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
[Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of PARP1 protein; [Cladribine co-treated with Cyclophosphamide] results in decreased expression of PARP1 protein Cladribine results in increased cleavage of PARP1 protein |
CTD |
PMID:15582267 PMID:21679466 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
multiple interactions |
ISO |
Cladribine promotes the reaction [Bendamustine Hydrochloride results in decreased expression of PAWR protein] |
CTD |
PMID:12948851 |
|
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pten |
phosphatase and tensin homolog |
multiple interactions increases expression decreases methylation |
ISO |
Cholecalciferol promotes the reaction [Cladribine results in increased expression of PTEN mRNA]; Cholecalciferol promotes the reaction [Cladribine results in increased methylation of PTEN promoter]; Cladribine promotes the reaction [Cholecalciferol results in decreased methylation of PTEN promoter]; Cladribine promotes the reaction [Cholecalciferol results in increased expression of PTEN mRNA]; resveratrol promotes the reaction [Cladribine results in decreased methylation of PTEN promoter] |
CTD |
PMID:21801466 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases phosphorylation |
ISO |
Cladribine results in increased phosphorylation of STAT3 protein |
CTD |
PMID:21679466 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
ISO |
Cladribine results in increased expression of TNF protein |
CTD |
PMID:10540334 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
affects activity |
ISO |
Cladribine affects the activity of TP53 protein; Cladribine metabolite affects the activity of TP53 protein |
CTD |
PMID:35435491 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
multiple interactions |
ISO |
Cladribine promotes the reaction [Bendamustine Hydrochloride results in decreased expression of XIAP protein] |
CTD |
PMID:12948851 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|